Perimenopause

Most women typically think about hot flashes, osteoporosis and insomnia when it comes to perimenopausal symptoms, not itchy or sensitive eyes. Yet, women are more affected by eye disease than men and dry eye syndrome in particular is commonly associated with menopause. In the United States, millions of people age 50 or older have dry eye syndrome with the majority of these being women.

Ocular dryness results from a chronic lack of sufficient lubrication on the surface of the eye due to tear deficiency or excessive tear evaporation. There are many causes including medications, smoking, LASIK surgery and environmental conditions. But dry eye syndrome is more frequent in post-menopausal women, affecting about 60% of menopausal women, due to hormonal fluctuations. Although symptoms typically begin as mild, if left untreated, the cornea can become scarred or infection may result.

Do You Suffer from Dry Eye Syndrome?

Symptoms of dry eye syndrome include:

  • Persistent dryness
  • Scratchy or gritty feeling
  • Stringy mucus
  • Irritation
  • Burning
  • Feeling as if something is in the eye
  • Watery eyes
  • Redness
  • Contact lens intolerance
  • Light sensitivity

Treatment for Dry Eyes

Since dry eye syndrome can progress from subtle irritation to inflammation or infection of eye tissues, a visit to an eye specialist is recommended if symptoms persist. Treatment typically begins with the application of artificial tears, lubricating eye drops or gels, applied every few hours. Lubricating eye ointments are thicker, last much longer and are typically used to lubricate the eyes overnight.

If symptoms persist, drops containing cyclosporine may be prescribed to decrease the inflammation associated with dryness.

Healthy Aging Eyes

In addition to dry eye syndrome, other eye diseases may arise post-menopause. The leading causes of vision impairment and blindness are primarily age related eye diseases. Cataract, glaucoma, macular degeneration and diabetic retinopathy are all major health concerns with aging – with a greater prevalence of glaucoma and macular degeneration in women. There seems to be a link between the onset of menopause and macular degeneration – the leading cause of vision loss and blindness in Americans aged 65 and older.

The number of women with age-related eye disease is expected to double within the next three decades. A recent study published in the journal Ophthalmology reports that postmenopausal women using hormone therapy for a long period of time may be at an increased risk for cataract extraction, especially those drinking more than one alcoholic drink daily.

For maintaining healthy eyes as you age, strive for a complete exam with an eye specialist every 1 to 2 years, taking extra care if you have diabetes or a family history of eye disease. Diabetic retinopathy causes 12,000 to 24,000 new cases of blindness each year – a number on the rise with the relentless diabetes epidemic.

Menopause marks a transition to new health risks for women but with lifestyle adjustments and proactive medical care, these risks can be managed. For many, eye health has never been a concern in the past, but like many other changes that occur as we age, it should become a consideration as we schedule our annual health exams and forge a new path post-menopause for healthy aging.

Get Primed! Tip: Schedule regular eye exams at the same time you schedule your other annual exams.

Follow us on Twitter:  @getprimedcoach

{ 0 comments }

As women approach perimenopause and menopause, weight gain becomes a challenging issue. On average, middle aged women gain about a pound a year with body composition shifting to more fat and less muscle. The weight gain is particularly frustrating since many women discover that weight loss strategies that may have worked in earlier years are no longer effective. There are serious health implications associated with the extra pounds, including increased risk of cardiovascular disease, diabetes and certain types of cancers, thus minimizing weight gain is critical for healthy aging. However, adoption of new weight loss strategies should be safe and must include enduring life style adjustments for long term success. Unfortunately many women search for a quick fix and some are turning to risky procedures such as lipodissolve.

Lipodissolve is Unregulated

Lipodissolve, billed as non-surgical fat removal, is an unregulated and potentially dangerous procedure offered by spas across the U.S. Spas offer lipodissolve, as a series of injections described as a “fat-melting” alternative to liposuction. The process is also known as injection lipolysis, lipozap, lipotherapy, and mesotherapy. There is no standardized list of ingredients for these injections since they are typically chemical cocktails with a makeup that varies depending on the pharmacy or spa that prepares the injections. The American Society for Aesthetic Plastic Surgery (ASAPS) reports a range of adverse effects including infections, defects and tissue death after lipodissolve. The FDA has reports of permanent scarring, skin deformation, deep, and painful knots under the skin in areas where the lipodissolve treatments were injected.

FDA Cracks Down on “Fat-Melting”

The Food and Drug Administration (FDA) is cracking down with long overdue warnings for the claims spas are making about lipodissolve since the injections have not been proven safe or effective and are not approved by the agency.

FDA warnings have gone out to six U.S companies:

  • Monarch Medspa in King of Prussia, PA
  • Spa 35 in Boise, ID
  • Medical Cosmetic Enhancements in Chevy Chase, MD
  • Innovative Directions in Health in Edina, MN
  • PURE Med Spa in Boca Raton, FL
  • All About You Med Spa in Madison, IN

So although a quick-fix for menopause weight gain may be tempting, lipodissolve is not FDA-approved and the safety and efficacy of the procedure has not been established.

{ 0 comments }

Low Dose Estrogen Therapy to Reduce Painful Intercourse

December 30, 2009

FDA approval of a lower dose (10mcg) formulation of Vagifem (estradiol vaginal tablets, from Novo Nordisk) for the treatment of atrophic vaginitis due to menopause.

Read the full article →